Alpha Tau Medical (DRTS) Total Liabilities (2020 - 2026)
Alpha Tau Medical (DRTS) reported Total Liabilities of $39.4 million for Q1 2026, up 60.23% on a YoY basis from $24.6 million in Q1 2025, and up 38.06% sequentially from $28.6 million in Q4 2025.
Alpha Tau Medical (DRTS) Total Liabilities (2020 - 2026) Analysis & Trends
Alpha Tau Medical (DRTS) has 7 years of Total Liabilities data on file, last reported at $39.4 million in Q1 2026.
- For the quarter ending Q1 2026, Total Liabilities rose 60.23% year-over-year to $39.4 million; the trailing twelve-month figure through Mar 2026 stood at $39.4 million (up 60.23% YoY), and the FY2025 full-year result was $28.6 million, up 21.31% from the prior year.
- Total Liabilities climbed to $39.4 million in Q1 2026, from $28.6 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $39.4 million in Q1 2026 to a low of $12.1 million in Q3 2022.
- A 5-year average of $22.2 million and a median of $22.9 million in 2023 frame the typical range for Total Liabilities.
- Across the five-year window, Total Liabilities slumped 37.07% in 2022 and jumped 60.23% in 2026, its largest moves.
- Tracing DRTS's Total Liabilities over 5 years: stood at $14.5 million in 2022, then surged by 58.11% to $22.9 million in 2023, then climbed by 2.73% to $23.5 million in 2024, then gained by 21.31% to $28.6 million in 2025, then soared by 38.06% to $39.4 million in 2026.
- Business Quant data shows DRTS's Total Liabilities at $39.4 million in Q1 2026, $28.6 million in Q4 2025, and $27.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 60.46 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | 177.22 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 19.51 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 3.79 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 7.12 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 9.45 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 15.48 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 753.82 Mn |
| 10 | Alpha Tau Medical | 1.12 Bn | 1.04 Bn | - | 39.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 39.42 Mn |
| Dec 31, 2025 | 28.55 Mn |
| Sep 30, 2025 | 27.11 Mn |
| Jun 30, 2025 | 24.33 Mn |
| Mar 31, 2025 | 24.60 Mn |
| Dec 31, 2024 | 23.54 Mn |
| Sep 30, 2024 | 21.33 Mn |
| Jun 30, 2024 | 22.03 Mn |
| Mar 31, 2024 | 23.38 Mn |
| Dec 31, 2023 | 22.91 Mn |
| Sep 30, 2023 | 16.89 Mn |
| Jun 30, 2023 | 18.64 Mn |
| Mar 31, 2023 | 16.88 Mn |
| Dec 31, 2022 | 14.49 Mn |
| Sep 30, 2022 | 12.11 Mn |
| Jun 30, 2022 | 15.71 Mn |
| Mar 31, 2022 | 25.05 Mn |
| Dec 31, 2021 | 23.03 Mn |
| Dec 31, 2020 | 7.45 Mn |